Results 101 to 110 of about 6,119 (209)

The efficacy and safety of patient-controlled intravenous analgesia with esketamine after total hip arthroplasty: a randomized controlled trial

BMC Anesthesiology
Purpose To evaluate the efficacy and safety of esketamine-based patient-controlled intravenous analgesia following total hip arthroplasty. Methods A total of 135 total hip arthroplasty patients were randomly assigned to one of the three treatment groups:
Song Qu, Wen-Jie Zhang, Hai-Jiao Zhou, Fei Deng, Rui-Juan Liu, Wen-Jun Yan   +5 more
doaj   +1 more source

Comparison Between Low-Dose Esketamine and Dexmedetomidine on Postoperative Recovery Quality Among Patients Undergoing Humeral Trauma Surgery in Interscalene Brachial Plexus Block: A Randomized, Double-Blind, Controlled Trial

Jiao Chen,1,2,* Yu Qi,1,2,* Jun Zhang,1,3,* Bin Sun,1,2 Meng Zhang,2 Xiangdi Meng,2 Meiyan Zhou,1,2 Liwei Wang1,2 1The Xuzhou Clinical College of Xuzhou Medical University, Jiangsu, People’s Republic of China; 2Department of ...
Zhou M, Chen J, Zhang J, Sun B, Qi Y, Zhang M, Meng X, Wang L   +7 more
core  

Is there a risk of esketamine misuse in clinical practice?

In 2019, intranasal esketamine gained approval as a promising therapy for those individuals grappling with treatment-resistant depression. Both clinical trials and real-world studies have underscored its efficacy in alleviating and remitting depressive ...
Milton Merizalde-Torres, Francisco Javier Álvarez, Carlos Roncero, Marta Torrens, Néstor Szerman, Pilar Andres-Olivera, Pablo Vega   +6 more
core   +1 more source

Ketamine/Esketamine and Suicidality - Systematic Review

Effects of ketamine and esketamine on death, suicidal behaviour, and suicidal ideation in psychiatric disorders: A systematic review and meta ...
Joanna Moncrieff, Martin Plöderl
core   +1 more source

Intranasal esketamine for patients with major depressive disorder: A systematic review and meta-analysis

A large number of people worldwide grapple with Major Depressive Disorder (MDD), and a significant portion of them confront resistance to conventional antidepressant treatments.
Alinejadfard, Mohammadreza, Fanaei, Maryam, Golsorkh, Hossein, Centis, Rosella, D'Ambrosio, Lia, Goudarzi, Hossein, Sadeghian, Majid, Sotgiu, Giovanni, Migliori, Giovanni Battista, Nasiri, Mohammad Javad, Oraee, Soroush   +10 more
core   +1 more source

Tolerability of intranasal esketamine, a case series of 15 patients

Introduction Intranasal esketamine has recently been approved for the treatment of treatment-resistant depression in adults, with different studies showing its efficacy and tolerability.
H. J. Vizcaíno Herrezuelo, L. Gayubo Moreo, C. Delgado Marmisa, L. Egüen Recuero, B. Sanz-Aránguez Ávila, I. Álvarez Correa, E. Garrido Dobrito, R. de Arce Cordón, L. D. Téllez de Cepeda, L. Caballero Martínez   +9 more
core   +1 more source

Comparison of Esketamine/Propofol and Sufentanil/Propofol on Intraoperative Hypoxemia During Bronchoscopy: A Randomized Trial

Drug Design, Development and Therapy
Xiao Huang,1 Xueyang Li,1 Yuan Sun,2 Anshi Wu,1 Pan Ai1 1Department of Anesthesiology, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, People’s Republic of China; 2Department of Pharmacy, Peking University Third Hospital, Beijing, People’
Huang X, Li X, Sun Y, Wu A, Ai P
doaj  

Intranasal Esketamine Versus Other Pharmacological Strategies in Treatment-Resistant Depression with High Suicide Risk: A Six-Month Naturalistic Study. [PDF]

Clin Pract
de Granda-Beltrán AM, Porras-Segovia A, Núñez-Arias D, Rodríguez-Jover A, Jassir Acosta MP, Courtet P, Baca-García E, Peñuelas-Calvo I.   +7 more
europepmc   +1 more source

Efficacy of esketamine for perinatal depression: A systematic review and meta-analysis

Objective Postpartum depression (PPD), now referred to as perinatal depression, is a prevalent and debilitating mood disorder that reduces health-related quality of life (HRQoL) and psychosocial functioning.
Le, Gia Han, Wong, Sabrina, McIntyre, Roger S., Mansur, Rodrigo, Rhee, Taeho Greg, Ho, Roger, Rosenblat, Joshua D., Kwan, Angela T.H., Teopiz, Kayla M.   +8 more
core   +1 more source

Reply to: prophylactic esketamine to reduce postpartum depression in primiparae: A multicentre, double-blind, randomised clinical trial. [PDF]

Eur J Anaesthesiol
Chu T, Xu A, Gao F.
europepmc   +1 more source